Lv4
570 积分 2022-05-31 加入
Phase 3 Trials of Elafibranor and Seladelpar for Primary Biliary Cholangitis
1天前
已完结
A phase 1 study of intravenous mitazalimab, a CD40 agonistic monoclonal antibody, in patients with advanced solid tumors
2天前
已完结
Pericancerous cross-presentation to cytotoxic T lymphocytes impairs immunotherapeutic efficacy in hepatocellular carcinoma
4天前
已完结
First-line zorifertinib for EGFR-mutant non-small cell lung cancer with central nervous system metastases: The phase 3 EVEREST trial
15天前
已完结
Integrative multiomic analysis identifies distinct molecular subtypes of NAFLD in a Chinese population
16天前
已完结
Active regulation of amyloidosis
23天前
已完结
Convergent inducers and effectors of T cell paralysis in the tumour microenvironment
24天前
已完结
Multiscale drug screening for cardiac fibrosis identifies MD2 as a therapeutic target
28天前
已完结
HDAC inhibitors as pharmacological treatment for Duchenne muscular dystrophy: a discovery journey from bench to patients
30天前
已完结
Hydrazide-Based Class I Selective HDAC Inhibitors Completely Reverse Chemoresistance Synergistically in Platinum-Resistant Solid Cancer Cells
1个月前
已完结
皖公网安备34019202002308
